Cargando…
An Update on Eight “New” Antibiotics against Multidrug-Resistant Gram-Negative Bacteria
Infections in the ICU are often caused by Gram-negative bacteria. When these microorganisms are resistant to third-generation cephalosporines (due to extended-spectrum (ESBL) or AmpC beta-lactamases) or to carbapenems (for example carbapenem producing Enterobacteriales (CPE)), the treatment options...
Autores principales: | Yusuf, Erlangga, Bax, Hannelore I., Verkaik, Nelianne J., van Westreenen, Mireille |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962006/ https://www.ncbi.nlm.nih.gov/pubmed/33806604 http://dx.doi.org/10.3390/jcm10051068 |
Ejemplares similares
-
New-Generation Antibiotics for Treatment of Gram-Positive Infections: A Review with Focus on Endocarditis and Osteomyelitis
por: Bloem, Annemieke, et al.
Publicado: (2021) -
Stewardship of Antibiotics for Multidrug-Resistant Gram-Negative Bacteria
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2020) -
An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria
por: Elliott, Alysha G., et al.
Publicado: (2020) -
Cefiderocol, a new antibiotic against multidrug-resistant Gram-negative bacteria
por: Silva, José Tiago, et al.
Publicado: (2021) -
Combination antibiotic therapy for multidrug-resistant Gram-negative bacteria
por: Tängdén, Thomas
Publicado: (2014)